Latest news with #EmcurePharma
Time of India
6 days ago
- Business
- Time of India
Emcure, Sanofi tie up for anti-diabetic range
New Delhi: Emcure Pharma and Sanofi India announced that they entered into an exclusive distribution and promotion agreement for the latter's oral anti-diabetic products in India, effective immediately. Emcure will exclusively distribute and promote the range of products, which include brands like Amaryl and Cetapin.
&w=3840&q=100)
Business Standard
10-07-2025
- Business
- Business Standard
Emcure Pharma rises over 2% as USFDA issues Form 483 with Zero observations
Emcure Pharma share price: Pharmaceutical company Emcure Pharmaceuticals (Emcure Pharma) share price was buzzing in trade on Thursday, July 10, 2025, with the stock rising as much as 2,45 per cent to hit an intraday high of ₹1,287 per share. At 11:25 AM, Emcure Pharma share price continued to trade higher, up 1.39 per cent at ₹1,273.60. In comparison, BSE Sensex was trading 0.39 per cent lower at 83,206.68 levels. Why did Emcure Pharma share price rise today? Emcure Pharma share price rose in trade after the company announced that United States Food and Drug Administration (USFDA) issued Form 483 with zero observations, post pre-approval inspection (PAI), for its Sanand, Ahmedabad unit. The inspection was held between June 30, 2025 and July 8, 2025. In an exchange filing, Emcure Pharma said, 'This is to inform you that the United States Food and Drug Administration (USFDA) had conducted Pre-Approval Inspection (PAI) of Company's manufacturing facility (Oncology) located at GIDC, Taluka - Sanand, Ahmedabad, Gujarat, from June 30, 2025 to July 08, 2025. The inspection concluded without issuance of Form 483 (zero observations).' Emcure Pharma IPO listing Emcure Pharmaceuticals listed on the exchanges on July 10 last year i.e. 2024. The company made a solid debut with its shares listing at ₹1,325, a 31 per cent premium over its issue price of ₹1,008, on the National Stock Exchange (NSE) and BSE. About Emcure Pharma Emcure Pharma, headquartered in Pune, is among the leading global pharmaceutical companies recognised for its strong commitment to innovation, quality, and patient-centricity. Established in 1981, Emcure Pharmaceuticals has developed a diverse portfolio of pharmaceutical products across various therapeutic areas, aiming to improve patient health and well-being. As a research and development-driven organisation, the company specialises in manufacturing differentiated medicines designed to address the evolving needs of patients worldwide. Moreover, the company has established a major presence in over 70 countries, including key markets like Europe and Canada. With a focus on advancing healthcare through cutting-edge research and a broad product range, Emcure Pharmaceuticals continues to enhance its global footprint and contribute to the improvement of healthcare outcomes globally. The market capitalisation of Emcure Pharma is ₹24,135.78 crore, according to BSE. The company falls under the BSE 500 category.
News18
10-07-2025
- Business
- News18
Stocks To Watch: TCS, Akzo Nobel, Emcure Pharma, Adani Ent, Tata Technologies, And Others
Last Updated: Stocks to watch: Shares of firms like TCS, Akzo Nobel, Emcure Pharma, Adani Ent, Tata Technologies, and others will be in focus on Thursday's trade Stocks to Watch on Thursday, July 10, 2025: Equity markets continued their consolidation trend on Wednesday, ending the session slightly lower after trading within a narrow and volatile range. In today's session, shares of TCS, Akzo Nobel, Indosolar, Emcure Pharma, Enviro Infra, and others will be in focus due to key corporate developments and earnings announcements. Q1 Earnings Today The Q1FY26 earnings season kicks off today, with Tata Consultancy Services (TCS) leading the pack. Other companies scheduled to announce their financial results include IREDA, Tata Elxsi, Oswal Pumps, and Anand Rathi. India's largest IT services company, TCS, is set to report its Q1 earnings today. Analysts expect a modest net profit growth in the range of 1–3%, with key focus areas being margin performance, deal wins, and management commentary on demand outlook across sectors. Akzo Nobel Asian Paints has offloaded 20 lakh shares (4.42% stake) in Akzo Nobel for approximately Rs 734 crore. ICICI Prudential Mutual Fund was among the buyers, acquiring 7 lakh shares worth Rs 256 crore. Enviro Infra JV has secured a work order worth ₹395 crore from the Maharashtra Industrial Development Corporation (MIDC), which could boost revenue visibility for the company. Adani Enterprises Adani Enterprises Ltd's ₹1,000 crore bond issue was fully subscribed within three hours of opening on Wednesday, according to stock exchange data, reflecting strong investor appetite. Tata Technologies Tata Technologies Ltd, a global engineering and digital services firm, has announced a partnership with Emerson to provide integrated testing and validation solutions for global OEMs in the automotive, aerospace, and commercial vehicle sectors. Disclaimer:Disclaimer: The views and investment tips by experts in this report are their own and not those of the website or its management. Users are advised to check with certified experts before taking any investment decisions. view comments First Published: July 10, 2025, 07:57 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Economic Times
10-07-2025
- Business
- Economic Times
Stocks in news: TCS, Akzo Nobel, Indosolar, Emcure Pharma, Enviro Infra
Markets traded in a volatile but in a narrow range and ended marginally lower on Wednesday, extending the ongoing consolidation phase. In today's trade, shares of TCS, Akzo Nobel, Indosolar, Emcure Pharma, Enviro Infra among others will be in focus due to various news developments. ADVERTISEMENT TCS Indian IT bellwether TCS will announce its Q1 earnings today where the company is expected to report a net profit growth of 1-3%. Akzo Nobel Asian Paints sold 20 lakh shares (4.42% Equity) in Akzo Nobel for Rs 734 crore. ICICI Prudential MF bought 7 lakh shares for Rs 256 crore. Indosolar Indosolar, a subsidiary of Waaree Energies, announced an offer for sale (OFS) of up to 10 lakh equity shares, representing 2.4% of the company's total paid-up equity capital. Emcure Pharma Emcure Pharma said that the US FDA has concluded a pre-approval inspection at its oncology manufacturing facility in Ahmedabad without issuing a Form 483. ADVERTISEMENT Enviro Infra Enviro Infra JV received Rs 395 crore order from Maharashtra Industrial Development Corp. (You can now subscribe to our ETMarkets WhatsApp channel)
Time of India
10-07-2025
- Business
- Time of India
Stocks in news: TCS, Akzo Nobel, Indosolar, Emcure Pharma, Enviro Infra
Markets traded in a volatile but in a narrow range and ended marginally lower on Wednesday, extending the ongoing consolidation phase. In today's trade, shares of TCS , Akzo Nobel , Indosolar , Emcure Pharma, Enviro Infra among others will be in focus due to various news developments. TCS Indian IT bellwether TCS will announce its Q1 earnings today where the company is expected to report a net profit growth of 1-3%. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Arzt: "Tun Sie das sofort bei geschwollenen, schweren Beinen" (Video ansehen) Mehr erfahren Undo Akzo Nobel Asian Paints sold 20 lakh shares (4.42% Equity) in Akzo Nobel for Rs 734 crore. ICICI Prudential MF bought 7 lakh shares for Rs 256 crore. Indosolar Indosolar, a subsidiary of Waaree Energies , announced an offer for sale (OFS) of up to 10 lakh equity shares, representing 2.4% of the company's total paid-up equity capital. Live Events Emcure Pharma Emcure Pharma said that the US FDA has concluded a pre-approval inspection at its oncology manufacturing facility in Ahmedabad without issuing a Form 483. Enviro Infra Enviro Infra JV received Rs 395 crore order from Maharashtra Industrial Development Corp.
